More commonly used than droxidopa: Midodrine was approved in the 1990s (droxidopa was approved in 2014) Most clinicians have longer experience with midodrine Midodrine is available as a generic & is less expensive Droxidopa is typically reserved for use as an add-on when midodrine is ineffective, or midodrine is not tolerated due to side effects Contraindications: hypertension heart failure acute kidney failure urinary retention thyrotoxicosis pheochromocytoma Side Effects: Supine hypertension WARNING : may cause marked hypertension when the patient is supine (laying down)
Statements Author contributions GG and PS conceived the idea of the manuscript, wrote the introduction and the conclusions as well as prepared the figures
Cells were then incubated for 4 min at room temperature, centrifuged at 1000 x g for 3 min, washed once with 2 mL fresh HC -Ura-Leu medium and finally resuspended in fresh HC -Ura-Leu medium to an OD 600 of 7.5
NAD is used primarily for fatigue and low energy, brain fog and cognitive performance, post-viral recovery, healthy aging and longevity protocols, and as a cellular foundation for patients who want to optimize overall function
It is not intended for human consumption, veterinary use, therapeutic use, or diagnostic applications
